Clin Epidemiol. 2021 Jul 26;13:615-626. doi: 10.2147/CLEP.S298748. eCollection 2021.
Glycemic Control in Pregnancies Complicated by Pre-Existing Diabetes Mellitus and Congenital Malformations: A Danish Population-Based Study.
Clinical epidemiology
Linn Håkonsen Arendt, Lars Henning Pedersen, Lars Pedersen, Per Glud Ovesen, Tine Brink Henriksen, Morten Søndergaard Lindhard, Jørn Olsen, Henrik Toft Sørensen, Cecilia Høst Ramlau-Hansen
Affiliations
Affiliations
- Department of Obstetrics and Gynecology, Department of Clinical Medicine, Aarhus University Hospital, Aarhus, Denmark.
- Department of Public Health, Research Unit for Epidemiology, Aarhus University, Aarhus, Denmark.
- Department of Obstetrics and Gynecology, Regional Hospital Horsens, Horsens, Denmark.
- Department of Biomedicine, Aarhus University, Aarhus, Denmark.
- Department of Clinical Epidemiology, Aarhus University Hospital, Aarhus, Denmark.
- Steno Diabetes Center Aarhus, Aarhus University Hospital, Aarhus, Denmark.
- Department of Child and Adolescent Health, Aarhus University Hospital, Aarhus, Denmark.
- Department of Child and Adolescent Health, Regional Hospital Randers, Aarhus, Denmark.
PMID: 34345185
PMCID: PMC8325058 DOI: 10.2147/CLEP.S298748
Abstract
PURPOSE: To study the occurrence of major congenital abnormalities in children of women with type 1 and type 2 diabetes and investigate the association between glycated haemoglobin (HbA1c) and major congenital malformations according to type 1 diabetes and type 2 diabetes separately.
PATIENTS AND METHODS: In this register-based study, all singletons born alive from January 1, 2000 to December 31, 2015 in the North Denmark and Central Denmark regions of Denmark and their mothers were included. We used data from Danish health registers and the LABKA database. Logistic regression models were used to compute crude and adjusted prevalence odds ratios (cORs and aORs) with 95% confidence intervals (CIs) for major congenital malformations overall and for subtypes, by type of maternal pre-existing diabetes and HbA1c levels.
RESULTS: Among 314,245 infants included, 2020 (0.64%) had mothers with type 1 diabetes and 498 (0.16%) had mothers with type 2 diabetes. We found an aOR of 2.9 (95% CI: 2.5, 3.5) and 1.9 (95% CI: 1.3; 2.8) for major malformations for type 1 and type 2 diabetes, respectively. The highest occurrence was seen for major congenital heart diseases, but we also observed higher occurrence of several other non-cardiac malformations. For both type 1 and type 2 diabetes, the prevalence of major congenital malformations increased with higher levels of maternal HbA1c with no safe threshold level. Mothers with type 1 diabetes had higher risks than those without diabetes irrespective of HbA1c, and women with HbA1c levels ≥9.5% had 8 times the odds of major congenital malformations [aOR 8.7 (95% CI: 5.4; 14.5)].
CONCLUSIONS: The prevalence of major congenital malformations progressively increased with poorer glycemic control during pregnancy, with no obvious safe threshold level, for both type 1 and type 2 diabetes.
© 2021 Arendt et al.
Keywords: congenital heart diseases; diabetes; epidemiology; malformations; pregnancy; register-based research
Conflict of interest statement
The authors report no financial, personal, political, intellectual or religious conflicts of interest. The findings have not previously been presented at conferences.
References
- Lancet. 2011 Jul 2;378(9785):31-40 - PubMed
- BMJ. 2004 Apr 17;328(7445):915 - PubMed
- Diabetes Care. 2009 Jun;32(6):1046-8 - PubMed
- Scand J Public Health. 2003;31(1):12-6 - PubMed
- BMC Med Res Methodol. 2011 May 28;11:83 - PubMed
- Diabetologia. 2017 Sep;60(9):1668-1677 - PubMed
- Diabetologia. 2012 Feb 8;: - PubMed
- Dan Med Bull. 1998 Jun;45(3):320-3 - PubMed
- Epidemiology. 2014 Nov;25(6):866-71 - PubMed
- Diabetes Care. 2020 Jan;43(Suppl 1):S183-S192 - PubMed
- Scand J Public Health. 2011 Jul;39(7 Suppl):30-3 - PubMed
- BMJ. 2018 Jul 5;362:k2638 - PubMed
- Clin Epidemiol. 2011 Feb 16;3:61-6 - PubMed
- BMC Pregnancy Childbirth. 2015 Mar 27;15:69 - PubMed
- Epidemiology. 2018 Sep;29(5):739-748 - PubMed
- Clin Epidemiol. 2017 Oct 03;9:483-489 - PubMed
- Drug Discov Ther. 2015 Aug;9(4):274-81 - PubMed
- J Urol. 2012 Oct;188(4):1324-9 - PubMed
- Circulation. 2016 Jun 7;133(23):2243-53 - PubMed
- Clin Epidemiol. 2015 Nov 17;7:449-90 - PubMed
- Diabetologia. 2000 Jan;43(1):79-82 - PubMed
- Eur J Epidemiol. 2014 Aug;29(8):541-9 - PubMed
- Diabet Med. 2011 Sep;28(9):1060-7 - PubMed
- Best Pract Res Clin Endocrinol Metab. 2011 Dec;25(6):945-58 - PubMed
- Ugeskr Laeger. 2007 Apr 30;169(18):1687-92 - PubMed
- Clin Epidemiol. 2020 May 18;12:469-475 - PubMed
- Clin Epidemiol. 2010 Dec 02;2:273-9 - PubMed
- Endocrine. 2011 Oct;40(2):243-9 - PubMed
- BMC Pregnancy Childbirth. 2006 Oct 30;6:30 - PubMed
- Dan Med Bull. 2006 Nov;53(4):441-9 - PubMed
- Nutr Metab Cardiovasc Dis. 2008 May;18(4):291-7 - PubMed
- J Matern Fetal Neonatal Med. 2019 Apr;32(8):1225-1229 - PubMed
Publication Types